Blocking polyphosphates could help treat chronic infections

Most disease-causing bacteria are known for their speed: In mere minutes, they can double their population, quickly making a person sick.

FDA raises questions about Lilly’s Alzheimer’s drug; Adcomm votes against MDMA therapy; Inside Walmart Health’s challenges; and more

Sign up for free to read a limited number of articles each month. Pick what newsletters get delivered to your inbox each week. Biopharma ENDPOINTS

June 9, 2024

Assessing recurrence risk with ctDNA-based MRD detection in NSCLC patients

In operable non-small cell lung cancer (NSCLC), molecular residual disease (MRD) detection via circulating tumor DNA (ctDNA) has emerged as a promising approach to identify

November 7, 2024

Novartis hands PeptiDream $180M upfront to extend radiopharma discovery pact

Novartis is looking to build on its radiopharma research machinery. The maker of Lutathera and Pluvicto has expanded its longstanding peptide discovery deal with PeptiDream

May 1, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.